Vaccinia Virus Inoculation in Sites of Allergic Skin Inflammation Elicits a Vigorous Cutaneous IL-17 Response

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0904021106
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2016English

Vaccinia Virus Meningitis in Mice After Intracerebral Inoculation.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1976English

Pathogenesis of Allergic Inflammation With Participation of Il-17 and Il-23 Cytokines in Patients With Chronic Epstein-Barr Virus Persistence in Active and Latent Phases

Asthma and allergy
2019English

IL-17 in Inflammation and Diseases

KAGAKU TO SEIBUTSU
2011English

Resolution of Allergic Airway Inflammation and Airway Hyperreactivity Is Mediated by IL-17–producing γδT Cells

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2010English

IL-20-receptor Signaling Delimits IL-17 Production in Psoriatic Inflammation

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2020English

Retraction: Role of IL-33 in Allergic Inflammation and Diseases

Journal of Japan Society of Immunology & Allergology in Otolaryngology
2012English

Vaccinia Virus–specific Molecular Signature in Atopic Dermatitis Skin

Journal of Allergy and Clinical Immunology
AllergyImmunology
2010English

Allergen Specific Immunotherapy Decreases IL-17 and Increases IL-35 in Allergic Rhinitis Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy